STRONGBRIDGE BIOPHARMA PLC's ticker is SBBP and the CUSIP is G85347105. A total of 72 filers reported holding STRONGBRIDGE BIOPHARMA PLC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $48,000 | -70.7% | 16,300 | -72.6% | 0.00% | – |
| Q1 2021 | $164,000 | -79.8% | 59,400 | -82.2% | 0.00% | -100.0% |
| Q4 2020 | $810,000 | -12.6% | 333,141 | -24.5% | 0.00% | -33.3% |
| Q3 2020 | $927,000 | +260.7% | 441,452 | +548.4% | 0.00% | +200.0% |
| Q2 2020 | $257,000 | +73.6% | 68,082 | -12.8% | 0.00% | 0.0% |
| Q1 2020 | $148,000 | -18.7% | 78,047 | +92.3% | 0.00% | 0.0% |
| Q4 2018 | $182,000 | -82.7% | 40,590 | -81.3% | 0.00% | -66.7% |
| Q3 2018 | $1,054,000 | +62.9% | 217,381 | +101.5% | 0.00% | +50.0% |
| Q2 2018 | $647,000 | +397.7% | 107,875 | +633.8% | 0.00% | – |
| Q1 2018 | $130,000 | – | 14,700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CAXTON CORP | 5,376,039 | $47,309,000 | 51.34% |
| Lyon Street Capital, LLC | 3,182,149 | $28,162,000 | 9.07% |
| Opaleye Management Inc. | 1,590,000 | $14,071,000 | 4.02% |
| Broadfin Capital, LLC | 2,793,752 | $24,725,000 | 3.85% |
| Vivo Capital, LLC | 1,918,132 | $16,975,000 | 2.40% |
| ARMISTICE CAPITAL, LLC | 3,372,000 | $29,842,000 | 2.28% |
| PRECEPT MANAGEMENT LLC | 470,000 | $4,160,000 | 1.73% |
| NEA Management Company, LLC | 4,141,308 | $36,651,000 | 1.63% |
| Harvest Capital Strategies LLC | 825,000 | $7,301,000 | 1.14% |
| Granite Point Capital Management, L.P. | 567,895 | $5,026,000 | 0.49% |